Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ascorbate-2-phosphate in red cell preservation. Clinical trials and active components.

G L Moore1, D H Marks, R A Carmen

  • 1Division of Blood Research, Letterman Army Institute of Research, Presidio of San Francisco, California.

Transfusion
|May 1, 1988
PubMed
Summary

A new red cell additive solution (AS-005) containing ascorbate-2-phosphate (AsP) showed comparable red blood cell viability to Nutricel AS-3 in clinical trials. In vitro, oxalate within AsP was found to preserve 2,3-diphosphoglycerate during storage.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ranked placement of phage predation as a determinant of dehydration severity among cholera patients in Bangladesh.

The Journal of infectious diseases·2026
Same author

Molecular Methods to Detect <i>Vibrio cholerae</i> and Associated Bacteriophages among Diarrheal Patients in Bangladesh.

medRxiv : the preprint server for health sciences·2026
Same author

Ranked placement of phage predation as a determinant of dehydration severity among cholera patients in Bangladesh.

medRxiv : the preprint server for health sciences·2025
Same author

Cholera rapid diagnostic tests at the host-microbe interface: Key Considerations for Global Deployments.

medRxiv : the preprint server for health sciences·2025
Same author

Gold Standard Cholera Diagnostics Are Tarnished by Lytic Bacteriophage and Antibiotics.

Journal of clinical microbiology·2020
Same author

Association of cicatricial alopecia with chemical hair straightening.

The British journal of dermatology·2019

Area of Science:

  • Blood banking and transfusion medicine
  • Biochemistry of red blood cells
  • Preservation solutions

Background:

  • Maintaining red blood cell (RBC) viability and function during storage is critical for transfusion efficacy.
  • Additive solutions play a key role in extending RBC shelf life and preserving key metabolic parameters.
  • Ascorbate-2-phosphate (AsP) has been investigated as a component to enhance RBC storage.

Purpose of the Study:

  • To evaluate the efficacy of a novel red cell additive solution (AS-005) containing AsP for RBC storage.
  • To compare the performance of AS-005 against a control additive solution (Nutricel AS-3) in human clinical trials.
  • To investigate the in vitro effects of AS-005 on RBC parameters and identify the active component responsible for preserving 2,3-diphosphoglycerate (2,3-DPG).

Main Methods:

Related Experiment Videos

  • Human clinical trials using a crossover design comparing AS-005 and Nutricel AS-3.
  • Evaluation of RBC viability at 35 and 42 days of storage.
  • In vitro split-bag studies of AS-005 at different storage temperatures (2.5°C and 5.5°C).
  • Analysis of in vitro parameters including 2,3-DPG, glucose, pH, and adenosine triphosphate (ATP).
  • High-pressure liquid chromatography (HPLC) to identify components in AsP preparations.

Main Results:

  • No significant difference in red cell viability was observed between AS-005 and Nutricel AS-3 at 35 or 42 days in clinical trials.
  • In vitro studies showed significant differences in 2,3-DPG (threefold), glucose (fivefold), pH, and ATP between storage conditions.
  • HPLC confirmed the presence of 1-2% oxalate in AsP preparations.
  • In vitro data indicated that oxalate is the active component in AsP responsible for preserving 2,3-DPG.

Conclusions:

  • AS-005 demonstrates comparable red blood cell viability to Nutricel AS-3 in clinical settings.
  • Oxalate, present in AsP, is identified as the key component preserving 2,3-DPG during RBC storage.
  • Further research may be warranted to optimize additive solutions for enhanced RBC preservation.